Increasing Awareness about Oral Healthcare Driving Dental Bone Graft Substitutes and Other Biomaterials Market

Published Date : Sep 16, 2016

The expanding reimbursement options is driving the global dental bone graft substitutes and other biomaterials market. Key dental surgeons maintain that around one in every four dental implant procedures involves dental bone grafting. Hence, rise in the number of dental implants due to increased awareness about oral healthcare globally is expected to augment the usage of dental bone grafts substitutes and biomaterials. Another factor driving the market is the rising prevalence of oral problems. Although root canal is also an option, the shift towards improved versions of treatment has propelled the usage of dental implants. According to the World Health Organization (WHO) estimates, severe periodontal (gum) disease may even result in tooth loss, and this is found in more than 15% to 20% of the middle aged adults. As such, the market is expected to grow. 

Increase in Per Capita Healthcare Expenditure to Enhance Affordability of Dental Services

Increase in the disposable income of the people is increasing the affordability of various dental services, which is driving the demand for dental treatment procedures including dental implants. This is expected to boost the dental bone grafts substitutes and other biomaterials market. Dental tourism is increasing worldwide with the wide availability of cost-effective dental services in developing nations such as Mexico, Peru, India and China. The low cost of dental services in these developing nations is due to low labor cost, minimal government intervention, reduced insurance cost, and reasonable education fee.

Stringent Government Regulations to Hamper Growth of Market

Awareness about regulatory requirements is crucial for understanding the biological assessment of biomaterials and medical devices. ISO has categorized implantable devices in a segment that need to undergo rigorous clinical trials prior to receiving a PMA (pre-market approval). Such rigorous PMA tests make the devices expensive and difficult for an organization to get its product approved. Due to this, overall production or manufacturing cost of the product increases and with it the profit margin decreases for the manufactures, hampering the market.